Accueil > Publications > Bevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive SurgeryBevacizumab Does Not Reduce the Lymphocele Rate in Advanced Ovarian Cancer After Complete Cytoreductive Surgery28 mars 2018Anticancer Research DOI : 10.21873/anticanres.12468